The impact of biotechnology and molecular biology on the pharmaceutical industry
Hobden, A.N.; Harris, T.J.R.
Proceedings of the Royal Society of Edinburgh Section B (Biological Sciences) 99(1-2): 37-45
1992
DOI: 10.1017/s0269727000013038Document Number: 405618
Document emailed within 0-6 h
Related Documents
Baichwal, R.S. 1988: Benefits of biotechnology to pharmaceutical industry Hindustan Antibiotics Bulletin 30(3-4): 51-53Werner, R.G. 1986: New biotechnology as a logical outgrowth of molecular biology Arzneimittel-Forschung 36(9): 1429-1436
Robinson, D.S. 1994: Psychotropic drug labeling: regulatory, pharmaceutical industry, and clinical issues and perspectives. a pharmaceutical industry perspective on drug labeling Psychopharmacology Bulletin 30(1): 23-25
Iovanna, J.L. 2015: Impact of molecular biology on the natural history of pancreatic cancer La Revue du Praticien 65(3): 367-369
Weinberg, R.A. 1989: The impact of molecular biology on understanding of the human disease process Mount Sinai Journal of Medicine new York 56(5): 392-394
Shore, E.M.; Kaplan, F.S. 1995: Tutorial. Molecular biology for the clinician. Part II. Tools of molecular biology Clinical Orthopaedics and Related Research 320: 247-278
Mazza, P. 1993: Pharmaceutical biotechnology Bollettino Chimico Farmaceutico 132(7): 247-251
Anichini, A.; Cascinelli, N. 2000: Stem cells research: impact on molecular biology of cancer and prospects for therapy of neoplastic diseases Tumori 86(5): 375-380
Tabuchi, K.; Fukuyama, K. 1998: Neurosurgery and molecular biology: (series 4) molecular biology of oncogenesis No Shinkei Geka. Neurological Surgery 26(6): 468-476
Ducatman, A.M.; Coumbis, J.J. 1991: Chemical hazards in the biotechnology industry Occupational Medicine 6(2): 193-208
Schlumberger, H.D.; Stadler, P. 1997: Modern pharmaceutical biotechnology. Situation worldwide and in Germany 1995 Arzneimittel-Forschung 47(1): 106-110
Glatzel, P.S. 1997: Significance of biotechnology in reproductive biology and veterinary medicine Berliner und Munchener Tierarztliche Wochenschrift 110(5): 166-170
Arai, N.; Yokota, T.; de Vries, J.; Banchereau, J.; Takebe, Y.; Lee, F.; Arai, K. 1988: Molecular biology of T cell-derived lymphokines: structure and biology of interleukin 4 Developments in Biological Standardization 69: 57-63
Lisella, F.S.; Herring, L.W. 1988: Promising biotechnology industry raises unique safety, health issues Occupational Health and Safety 57(6): 62
Gaasterland, T.; Vingron, M. 2011: This special issue comprises the papers accepted for presentationat the 19th Annual International Conference on Intelligent Systemsfor Molecular Biology, joint with the 10th European Conference on Computational Biology, an official conference of the InternationalSociety for Computational Biology Bioinformatics 27(13): I1
Hakim, Z.; Kucukarslan, S. 1993: Regulation of biotechnology products in the global pharmaceutical market: the case of the European community and the United States Clinical Therapeutics 15(2): 442-458; Discussion 432
Gulino, A. 1999: Biotechnology and molecular diagnostics Forum 9(3 Suppl 3: 37-46
Sheikh, S.P.; Carisen, J.; Hansen, P.R.; Haunsø, S. 1997: Molecular biology and cardiology. Molecular mechanisms in heart failure Ugeskrift for Laeger 159(17): 2523-2528
Moreno, G.; Gamba, G. 1996: Molecular biology in medicine. I. Molecular structure of the gene Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 48(1): 81-84
Raab, G.K.; Sherman, B.M. 1991: The Impact of Biotechnology on Surgery in the 1990s Surgical Technology International I: 41-42